PATENT CLAIM ANALYSIS

Application Number: 16246988
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["546", "270700"]

Abstract:
Provided is a production method of a thiazole derivative represented by the formula (I), which has an adenosine A 2A  receptor antagonistic action and is useful as a therapeutic agent for, for example, Parkinson's disease, sleep disorder, analgesic resistance to opioid, migraine, movement disorder, depression, anxiety disorder and the like. Also provided is a production method of a compound represented by the formula (C), which contains (i) a step of reacting a compound represented by the formula (A) and a compound represented by the formula (B), and the like: (wherein R 1  represents furyl, R 4 , R 5  and R 6  are the same or different and each represents lower alkyl or aryl, R 2  represents pyridyl or tetrahydropyranyl, and X 1  represents halogen).

Claim (Index 21):
The crystal according to  claim 19 , which has peaks at 21.2\u00b0, 23.8\u00b0 and 27.0\u00b0 for the angles of diffraction (2\u03b8\u00b10.2\u00b0) as determined by powder X-ray diffraction.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.98718
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15541857', '14034880', '15748283', '12672784', '10343285']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8042860740537052
- 35 USC 102 Novelty (BERT): 0.5082353950682433
- Combined Prediction Score: 0.774681006155159
- Mean Citation Score: 283.60215000000005
- Max Citation Score: 305.54456
- Similarity Product: 253.5266735977077

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test